The protective effect of physical activity on breast cancer incidence may partially be mediated by inflammation. Systematic searches of Medline, EMBASE, and SPORTDiscus were performed to identify intervention studies, Mendelian randomization studies, and prospective cohort studies that examined the effects of physical activity on circulating inflammatory biomarkers in adult women. Meta-analyses were performed to generate effect estimates. Risk of bias was assessed, and the Grading of Recommendations Assessment, Development, and Evaluation system was used to determine the overall quality of the evidence. Thirty-five intervention studies and one observational study met the criteria for inclusion. Meta-analyses of randomized controlled trials (RCT) indicated that, compared with control groups, exercise interventions reduced levels of C-reactive protein (CRP) [standardized mean difference (SMD) = −0.27, 95% confidence interval (CI) = −0.62 to 0.08), tumor necrosis factor alpha (TNFα, SMD = −0.63, 95% CI = −1.04 to −0.22), interleukin-6 (IL6, SMD = −0.55, 95% CI = −0.97 to −0.13) and leptin (SMD = −0.50, 95% CI = −1.10 to 0.09). Owing to heterogeneity in effect estimates and imprecision, evidence strength was graded as low (CRP, leptin) or moderate (TNFα and IL6). High-quality evidence indicated that exercise did not change adiponectin levels (SMD = 0.01, 95% CI = −0.14 to 0.17). These findings provide support for the biological plausibility of the first part of the physical activity—inflammation—breast cancer pathway.

Women who perform higher levels of physical activity may have a reduced risk of developing breast cancer compared with women with lower levels of physical activity (1–3). Although the mechanisms that underlie this relationship are not clearly understood, inflammation, along with sex steroid hormones and insulin/IGF system signaling, are among the main proposed causal pathways (4, 5).

Inflammation is thought to be a key contributor to cancer growth and progression as it stimulates cell proliferation and influences the tumor microenvironment, enhancing the recruitment, proliferation, and function of protumorigenic auxiliary cells (6, 7). Regular physical activity may reduce inflammation via the production and release of myokines from skeletal muscle tissue (8, 9), reduced levels of body fat, slow age-related weight gain (8, 10), and by reducing production of proinflammatory cytokines by the immune system (8). Evidence from observational studies generally support these hypotheses, demonstrating an inverse relationship between physical activity levels and circulating biomarkers of inflammation in men and women (4, 11). However, the evidence from randomized physical activity intervention trials has been inconsistent. Although some trials report a decrease in inflammatory biomarkers physical activity interventions, others have not identified any changes (4, 11). The reasons for this heterogeneity are multifactorial and do not rule out a causal relationship (e.g., reflecting aspects of the intervention, such as type, intensity, or duration of physical activity; or design aspects such as adherence levels and length of follow-up). Thus, confirming an effect (if any effect), estimating its magnitude, and investigating heterogeneity, may help improve understanding of the mechanisms that underlie relationships of the physical activity with breast cancer risk.

The World Cancer Research Fund (WCRF) International and University of Bristol have developed a causal evidence synthesis framework for conducting systematic reviews of mechanistic pathways for exposure–cancer associations (12). We previously outlined this approach in our protocol paper (5), and applied the method to examine the mechanistic evidence for the sex steroid hormone and insulin/IGF system signaling pathways (13–16). We utilize this framework in the current review to assess the effect of physical activity on inflammatory biomarkers in women. The second part of our systematic review will evaluate the evidence that inflammatory biomarkers are in turn related to breast cancer risk (17). The combined evidence elucidated from both reviews will allow us to evaluate the likelihood that physical activity influences breast cancer risk via an impact on circulating inflammatory biomarkers.

This review has been conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement (18) and registered with PROSPERO (CRD4202165689), and a detailed protocol paper has been published (5). In brief, systematic searches of Medline (Ovid), EMBASE (Ovid), and SPORTDiscus were performed on February 23, 2021 (Supplementary Methods and Material; Table 1). Peer-reviewed randomized controlled trials (RCT), prospective cohort studies and Mendelian randomization studies were eligible for inclusion if they examined the effect of physical activity on circulating inflammatory biomarkers in postmenarche women. Inflammatory biomarker outcomes were identified via a novel text mining tool, TeMMPo (Text Mining for Mechanism Prioritization; ref. 19), in consultation with experts in the field (5). Biomarkers included: C-reactive protein (CRP); tumor necrosis factor alpha (TNFα); IL1, IL6, IL8, IL10, IL13, and IL1β, IFNγ chemokine ligand 2; adiponectin; and leptin. Risk of bias was assessed using the Cochrane Collaboration Tool for RCTs (20); ROBINS-I (Risk of Bias in Nonrandomized Studies of Interventions) for nonrandomized interventions; and ROBINS-E (Risk of Bias in Nonrandomized Studies of Exposures) for observational studies (21, 22). Noting there are no established tools to assess risk of bias in Mendelian randomization studies, we used the STROBE-MR to appraise reporting quality of included Mendelian randomization studies (23). The overall quality of evidence as well as the strength of findings for each physical activity—inflammatory biomarker relationship was appraised using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system (24). For all extracted outcomes, data were summarized and presented descriptively. Where study design, exposures, outcomes, and analyses were defined consistently in at least three separate studies, random-effects meta-analysis was used to generate a pooled standardized mean difference (SMD) with 95% confidence interval (CI). When greater than moderate heterogeneity (I2 > 30%) was identified, subgroup analysis or meta-regression were performed if the number of available studies (≥10 studies) permitted it. The subgroups were: menopausal status and exercise type. Variables considered in meta-regression included participant age, body mass index (BMI), and physical activity duration and intensity. All statistical analyses were performed using Stata version 16 (Stata Corporation).

Table 1.

GRADE appraisal for physical activity–inflammatory biomarkers pathways.

OutcomeMeta-analysis study n (participant n)Meta-analysis effect estimate SMD (95% CI)GRADE judgment
 CRP 12 (1, 210) −0.27 (−0.62 to 0.08) Lowa,b 
Cytokines 
 TNFα 8 (564) −0.63 (−1.04 to −0.22) Moderatea 
 IL1B NA NA Very low 
 IL6 11 (895) −0.55 (−0.97 to −0.13) Moderatea 
 IL8 NA NA Very low 
 IL10 NA NA Very low 
Adipokines 
 Adiponectin 5 (645) 0.01 (−0.14 to 0.17) High 
 Leptin 4 (586) −0.50 (−1.10 to 0.09) Lowa,b 
OutcomeMeta-analysis study n (participant n)Meta-analysis effect estimate SMD (95% CI)GRADE judgment
 CRP 12 (1, 210) −0.27 (−0.62 to 0.08) Lowa,b 
Cytokines 
 TNFα 8 (564) −0.63 (−1.04 to −0.22) Moderatea 
 IL1B NA NA Very low 
 IL6 11 (895) −0.55 (−0.97 to −0.13) Moderatea 
 IL8 NA NA Very low 
 IL10 NA NA Very low 
Adipokines 
 Adiponectin 5 (645) 0.01 (−0.14 to 0.17) High 
 Leptin 4 (586) −0.50 (−1.10 to 0.09) Lowa,b 

Abbreviations: CI, confidence interval; CRP, c-reactive protein; IL = interleukin; SMD, standardized mean difference (Hedges G); TNFα, tumor necrosis factor-alpha.

aGraded down due to high heterogeneity.

bGraded down due to imprecision.

Search results

Results of the systematic search and screening are presented in Fig. 1. From 8,634 records identified, 40 full-text articles met the criteria for inclusion. The most common reasons for full-text exclusion included study design (e.g., cross-sectional analyses), wrong population (e.g., males only or male and female data not stratified), inappropriate comparator (e.g., diet condition), or wrong outcomes (e.g., no inflammatory biomarkers). These included 23 parallel group RCTs (26 publications; refs. 25–50), three randomized cross-over trials (51–53), 9 nonrandomized interventions (10 publications; refs. 54–63), and one observational study (64).

Figure 1.

PRISMA flow diagram. This figure incorporates literature search, screening, and study selection. Reasons for full-text inclusion included duplicate study, publication type (e.g., review), study design (e.g., cross-sectional design), population (e.g., male only), intervention/exposure (e.g., physical activity and diet), comparator (e.g., diet or medication), and outcomes (e.g., no inflammation measures).

Figure 1.

PRISMA flow diagram. This figure incorporates literature search, screening, and study selection. Reasons for full-text inclusion included duplicate study, publication type (e.g., review), study design (e.g., cross-sectional design), population (e.g., male only), intervention/exposure (e.g., physical activity and diet), comparator (e.g., diet or medication), and outcomes (e.g., no inflammation measures).

Close modal

Study characteristics

The study characteristics tables are presented in Supplementary Methods and Material (Supplementary Tables S2A–S2D) and summarized in Table 1. Studies included either premenopausal (RCTs = 7, cross-over trials = 1, nonrandomized intervention = 7, observation study = 1), perimenopausal (nonrandomized intervention = 1), or postmenopausal (RCTs = 16, cross-over trials = 2, nonrandomized intervention = 3) women. The sample size ranged from 16 to 389 women in RCTs; 12 to 32 in cross-over studies, and 12 to 30 in nonrandomized interventions, with an observational study involving 58 participants. The interventions prescribed aerobic exercise (RCTs = 15, cross-over trials = 12, nonrandomized intervention = 6), resistance exercise (RCTs = 7, cross-over trials = 1, nonrandomized intervention = 2), combined aerobic and resistance exercise (RCTs = 2), plyometric exercise (nonrandomized intervention = 1), and core exercise (RCT = 1). Exercise interventions included acute exercise (i.e., a single exercise session, cross-over trials = 2, nonrandomized interventions = 8) or ongoing exercise (RCT = 21, cross-over trials = 1, nonrandomized interventions = 1). Of the ongoing interventions, the median intervention duration was 16 weeks, and the range was 8 to 52 weeks. The exposure in the observational study was accelerometer-measured physical activity energy expenditure. The comparison condition included an inactive/usual activity control (RCT = 20, cross-over trials = 1, nonrandomized intervention = 2), an exercise intervention of a different type or structure (RCT = 4, cross-over trials = 1), lower exercise dose or intensity (RCT = 2, cross-over trials = 1) different participant age group or menopause status (nonrandomized intervention = 3), menstrual cycle phase (nonrandomized interventions = 2), or anthropometry (nonrandomized interventions = 1). Outcomes included circulating CRP (RCT = 18, cross-over trials = 1, nonrandomized interventions = 3), TNFα (RCT = 12, nonrandomized intervention = 7, observational study = 1), IL1β (RCTs = 1, nonrandomized intervention = 2, observational study = 1), IL6 (RCTs = 15, cross-over trials = 1, nonrandomized interventions = 7, observational study = 1), IL8 (nonrandomized intervention = 1, observational study = 1), IL10 (RCTs = 2, nonrandomized intervention = 1), adiponectin (RCTs = 8, nonrandomized intervention = 1) and leptin (RCTs = 6).

Risk of bias

The risk-of-bias scores are presented in Supplementary Methods and Material (Supplementary Tables S3A–S3C). All RCTs and cross-over trials were judged to have a high risk of performance bias owing to the difficulty in blinding participants to their exercise intervention. A further nine RCTs were judged to have high attrition bias owing to poor intervention compliance and/or completion rates (i.e., <90% adherence or completion; refs. 27, 29, 34, 36, 42, 46–48, 50). In addition, one RCT and two cross-over trials were judged to have a high risk of bias as they did not clearly present the assay type, sensitivity, or reliability parameters (26, 52, 53). One RCT was also judged to have a high risk of bias as it did not clearly present control group outcomes (26). All nonrandomized interventions had at least moderate risk of bias owing to the potential of confounding explaining any observed physical activity—inflammation relationship. One nonrandomized intervention was judged to have a serious risk of bias as it did not present information about participant body composition or anthropometry (55). One RCT, two cross-over studies, and one nonrandomized intervention had an increased risk of bias as they did not provide clear information on assay sensitivity (26, 52, 53, 59). The prospective cohort study was judged to have a moderate risk of bias owing to the likely presence of confounding (64).

Effect of physical activity on inflammatory biomarkers

Meta-analysis was performed for RCTs that compared the effects of ongoing exercise interventions on CRP, TNFα, IL6, adiponectin, and leptin. Meta-analysis results are presented in Fig. 2 (CRP and cytokines) and Fig. 3 (adipokines). Subgroup, meta-regression, and funnel plot results are presented in Supplementary Methods and Materials (Supplementary Figs. S1–S5; Tables 4–5). Results from individual studies that were not included in the meta-analyses are also presented in Supplementary Tables S6A–S6D.

Figure 2.

Forest plots for effects of physical activity compared with usual activity control in RCTs. A forest plot for (A) TNFα, (B) IL6, and (C) CRP.

Figure 2.

Forest plots for effects of physical activity compared with usual activity control in RCTs. A forest plot for (A) TNFα, (B) IL6, and (C) CRP.

Close modal
Figure 3.

Forest plots for effects of physical activity interventions compared with usual activity in RCTs. A forest plot for (A) adiponection and (B) leptin.

Figure 3.

Forest plots for effects of physical activity interventions compared with usual activity in RCTs. A forest plot for (A) adiponection and (B) leptin.

Close modal

CRP

Circulating CRP was lower following exercise interventions (12 studies, n = 1,210; SMD = −0.27; 95% CI = −0.62 to 0.08; I2 = 87%) compared with control. However, there was high heterogeneity among studies, a confidence interval that crossed the null, and potential publication bias evident in the funnel plot.

Subgroup analysis could not explain the heterogeneity, as this remained high for each subgroup including pre- (I2 = 70%) and postmenopausal women (I2 = 89%), as well as aerobic (I2 = 89%) and resistance training (I2 = 64%). Meta-regression was also unable to explain the observed heterogeneity, as there was no clear relationship between the study effect estimate and mean participant age, mean BMI, intervention duration, or intervention intensity (Supplementary Table S4).

Individual studies not included in the meta-analysis mostly supported a decrease in CRP following prescribed exercise relative to a usual activity control (26, 32, 33, 41, 45, 50), although results of one study indicated that these decreases may not be sustained long term (24 months; ref. 33). In one study, there was no clear difference in the effect of a moderate or high dose (i.e., 150 vs. 300 minutes per week) of aerobic exercise; however, this may have been affected by participant adherence, as greater time spent in the target heart rate zone was associated with greater reductions in CRP (32). No difference was identified in the CRP response to exercise according to the menstrual cycle phase (54, 62).

Cytokines

Meta-analysis of RCTs identified a decrease in TNFα (8 studies, n = 564, SMD = −0.63, 95% CI = −1.04 to −0.22, I2 = 76%) and IL6 (11 studies, n = 895, SMD = −0.55, 95% CI = −0.97 to −0.13, I2 = 88%), following exercise interventions compared with control. Meta-analysis also identified high heterogeneity and potential publication bias evident in the funnel plots.

For TNF—a, heterogeneity remained high in subgroup analysis for pre- (I2 = 75%) and postmenopausal women (I2 = 79%), as well as aerobic (I2 = 84%) and resistance training (I2 = 91%). There were too few studies to allow meta-regression to explore heterogeneity for TNF-a. For IL6, heterogeneity remained high in the subgroup analysis of studies that included only postmenopausal women (I2 = 94%) or prescribed only aerobic training (I2 = 59%) but not for studies of premenopausal women (I2 = 0%) or resistance training (I2 = 0%). Meta-regression indicated that participant BMI at baseline explained some of the heterogeneity in the observed IL6 effect estimates (β (95% CI) = 0.17 (0.03–0.30), as did intervention duration [β (95%CI) = 0.02, 95% CI = 0.01–0.03].

In individual studies not included in the meta-analyses, both TNFα and IL6 levels decreased following aerobic and resistance exercise interventions (31, 32, 45, 50, 59, 61). The decrease was not affected by aerobic exercise dose (32); however, for IL6, more time spent exercising at higher intensities was associated with greater decreases (32). In one study, the decrease in IL6 was more evident in participants with a larger compared with a smaller waist size (53). Three nonrandomized interventions showed an increase in IL6 levels following acute exercise (55, 56, 58).

In individual studies, acute exercise preceded an increase in IL1β and IL10 and a decrease in IL8 (55, 59, 63). Ongoing exercise resulted in a decrease of IL1β, no evidence of change in IL8, and an increase in IL10 (29, 42, 45, 47). There were too few studies to facilitate meta-analyses for cytokines IL1, IL1β1β, IL8, IL10, or IL13.

One observational study examined whether physical activity energy expenditure predicted prospective changes in IL1β, IL6, and IL8 (64). No evidence of any relationships was reported for these outcomes.

Adipokines

No evidence of any changes in adiponectin following exercise interventions compared with control was identified in the meta-analysis (5 studies, n = 645, SMD = 0.01, 95% CI = −0.14, 0.17, I2 = 0%). In contrast, there was evidence of a decrease in leptin following exercise (4 studies, n = 586, SMD = −0.50, 95% CI = −1.10, 0.09, I2 = 89%). However, for leptin, meta-analysis identified high heterogeneity between studies, confidence intervals that crossed the null, and possible publication bias (Supplementary Fig. SF5). There were too few studies to investigate heterogeneity for leptin as an outcome.

In individual studies not included in the meta-analysis, there was little evidence that adiponectin levels changed following acute exercise, but there was evidence that levels increased following ongoing aerobic or core exercise (44, 50, 57). There was little evidence that leptin levels changed following acute exercise but there was evidence that levels decreased following ongoing exercise (44, 58).

GRADE appraisal results are presented in Table 1. The evidence for an effect of physical activity on CRP, TNFα, IL6, adiponectin, and leptin in women was initially graded as high, as findings were based on meta-analyses of RCTs. The GRADE rating for physical activity to TNFα and IL6 was downgraded to moderate owing to high heterogeneity in effect estimates between studies. The ratings for CRP and leptin were downgraded to low owing to high heterogeneity in effect estimates between studies and lower certainty attributable to wide confidence intervals. The evidence for an effect of physical activity on IL1, IL1β1β, IL8, and IL10 was graded as very low, as there were insufficient studies to perform meta-analysis or support any definitive conclusions.

Meta-analysis identified decreases in circulating CRP, TNF-a, IL6, and leptin following exercise interventions compared with control. Effect sizes indicated a small (leptin) or medium (CRP, TNF-a, IL6) sized effect, but the quality of evidence was graded as low (CRP, leptin) or moderate (TNF-a, IL6) owing to high heterogeneity, wide confidence intervals, and potential publication bias. There was high-quality evidence that adiponectin did not change following exercise intervention. Our results support a likely decrease in select inflammatory biomarkers in response to physical activity; however, the level of confidence in this effect is limited.

Several strengths and limitations should be considered when interpreting the findings of this review. A key strength is the robust methodology employed to identify, synthesize, and appraise the evidence for the physical activity–inflammatory biomarker pathway in women. Conclusions are primarily based on meta-analysis results of RCTs, which is also a strength, as RCTs often provide a strong level of evidence. However, as the included RCTs focused more on the efficacy of structured exercise programs and less on physical activity completed in real-world settings, the effectiveness of real-world physical activity on inflammatory biomarkers remains unclear. Although observational and Mendelian randomization studies were eligible for inclusion, only one observational study identified by the systematic search was considered relevant. The greater availability of epidemiologic studies may have provided additional insight into the relationship between physical activity and inflammation in women at a population level. Several individual RCTs were limited by intervention completion and adherence, further complicating the ability to discern true effects. The strict study inclusion criterion, i.e., only including postmenarche women free from disease, is a review strength as it limits potential sources of bias. However, it may have limited the quantity of evidence available as well as the potential generalizability of review findings. As with all systematic reviews, it is possible that some relevant literature was not identified by the search strategy employed. However, following a review of reference lists for included papers and comparison with other reviews, we are confident that the results provide an accurate synthesis of current evidence.

The overall findings of our review are like those that examined the relationship between exercise training on inflammation in animals, older persons, or postmenopausal women (9, 65–68). Although this implies robust findings, we note our review identified smaller effect estimates for outcomes CRP and IL6 compared with the review by Khalafi and colleagues (65). This difference may be due to study inclusion criteria: although our review only included women who were free from disease, Khalafi and colleagues (65) included several studies of women that had cancer or metabolic syndrome at baseline. Including participants with preexisting disease may imply higher levels of inflammation at baseline and greater potential for exercise-induced changes.

Subgroup analysis and meta-regression were unable to provide clear insight into the reasons for the high heterogeneity observed. For most inflammatory biomarkers, heterogeneity remained high within trials that examined only pre- or postmenopausal women or specific types of exercise. Meta-regression did suggest that mean participant BMI at baseline was related to the size of an exercise—IL6 effect, which may suggest a mediating role of body composition. This finding was supported by those of individual RCTs included in our review, where fat loss was identified as a mediator of some exercise—inflammation effects (28, 31). Further, there was no change evident in adiponectin, which is produced by adipocytes, and only low-quality evidence of a small change in leptin, also produced by adipocytes.

Several recommendations can be made to improve the evidence quality for physical activity and inflammatory biomarkers in women. Given the low to moderate evidence strength, additional RCTs are still needed to clarify the effects of exercise on inflammation and to better understand reasons for variability within participant responses. Causal mediation analysis can be used to provide greater insight into the direct effects and indirect effects (e.g., via anthropometric change) of physical activity on inflammatory markers. Interaction analysis may also provide new information on who is likely to experience inflammation change in response to physical activity. Further, as meta-analysis was only possible for a select number of potentially relevant biomarkers identified via TeMMPo, there is a need for physical activity studies to expand the scope of inflammatory outcomes examined. Myokines, which are released by skeletal muscle in response to exercise (9), are proposed to have an anti-inflammatory effect and may contribute to the regulation of tumor growth (69), were not mechanisms prioritized by TeMMPo. As TeMMPo prioritizes mechanisms based on the quantity of evidence, this suggests the evidence base for a physical activity–myokines–breast cancer pathway still requires development. Evidence that physical activity protects against breast cancer is predominantly based on findings from observational studies that use measures of real-world physical activity (2). Despite this, most evidence for this mechanistic pathway came from trials that feature carefully prescribed exercise interventions. Information on the benefit of strategies like breaking up sitting time or accruing physical activity outside of structured exercise is needed to inform public health guidelines.

Physical activity is unlikely to affect breast cancer risk via a single pathway. This review is part of a series of reviews examining the evidence for potential mechanistic pathways that may explain the physical activity–breast cancer relationship (5). Our previous reviews have identified strong evidence for a physical activity–sex steroid hormones–breast cancer pathway. They also identified strong evidence for an effect of physical activity on insulin but not for insulin on breast cancer risk. Compared with sex steroid hormones and insulin signaling (14, 15), the effect estimates for physical activity and inflammatory biomarkers were generally higher, but the quality of evidence was lower and estimates less precise. Despite limitations in evidence quality, overall, findings mostly suggest a decrease in inflammation after physical activity. Part 2 of this review will examine the evidence for these inflammatory biomarkers as contributors to breast cancer risk (17).

C.T. Swain reports grants from World Cancer Research Fund (WCRF) during the conduct of the study. R.L. Milne reports grants from WCRF during the conduct of the study. D.R. English reports grants from WCRF during the conduct of the study. K.A. Brown reports grants from NIH/NCI during the conduct of the study. L. Boing reports grants from Coordenação de Aperfeicoamento de Pessoal de Nível Superior (CAPES) during the conduct of the study. T.R. Gaunt reports grants from WCRF during the conduct of the study; and T.R. Gaunt has received research funding from pharmaceutical companies for unrelated work. R.M. Martin reports grants from Cancer Research UK during the conduct of the study. B.M. Lynch reports grants from Wereld Kanker Onderzoek Fonds (WKOF) and Victorian Cancer Agency during the conduct of the study. No disclosures were reported by the other authors.

Funding (IIG_2018_1732) was obtained from WKOF, as part of the WCRF International Grant Program. K.A. Brown is supported by NIH/NCI R01 CA215797. E.H. van Roekel is funded by WKOF, as part of WCRF International Grant Program (grant No. 2016/1620). R.M. Martin is a National Institute for Health Research Senior Investigator (NIHR202411). R.M. Martin and S.J. Lewis were supported by the NIHR Biomedical Research Centre at University Hospitals Bristol and Weston NHS Foundation Trust and the University of Bristol and by a Cancer Research UK (C18281/A29019) program grant (the Integrative Cancer Epidemiology Programme). B.M. Lynch was supported by a Fellowship from the Victorian Cancer Agency (MCRF18005).

The publication costs of this article were defrayed in part by the payment of publication fees. Therefore, and solely to indicate this fact, this article is hereby marked “advertisement” in accordance with 18 USC section 1734.

Note: Supplementary data for this article are available at Cancer Epidemiology, Biomarkers & Prevention Online (http://cebp.aacrjournals.org/).

1.
Chan
DSM
,
Abar
L
,
Cariolou
M
,
Nanu
N
,
Greenwood
DC
,
Bandera
EV
, et al
.
World cancer research fund international: Continuous update project—systematic literature review and meta-analysis of observational cohort studies on physical activity, sedentary behavior, adiposity, and weight change and breast cancer risk
.
Cancer Causes Control
2019
;
30
:
1183
200
.
2.
McTiernan
A
,
Friedenreich
CM
,
Katzmarzyk
PT
,
Powell
KE
,
Macko
R
,
Buchner
D
, et al
.
Physical activity in cancer prevention and survival: a systematic review
.
Med Sci Sports Exerc
2019
;
51
:
1252
61
.
3.
Dixon-Suen
SC
,
Lewis
SJ
,
Martin
RM
,
English
DR
,
Boyle
T
,
Giles
GG
, et al
.
Physical activity, sedentary time and breast cancer risk: a mendelian randomisation study
.
Br J Sports Med
2022
;
56
:
1157
70
.
4.
McTiernan
A
.
Mechanisms linking physical activity with cancer
.
Nat Rev Cancer
2008
;
8
:
205
11
.
5.
Lynch
BM
,
Milne
RL
,
English
DR
,
Brown
KA
,
Drummond
AE
,
Swain
CTV
, et al
.
Linking physical activity to breast cancer: text mining results and a protocol for systematically reviewing three potential mechanistic pathways
.
Cancer Epidemiol Biomarkers Prev
2022
;
31
:
11
5
.
6.
Coussens
LM
,
Werb
Z
.
Inflammation and cancer
.
Nature
2002
;
420
:
860
7
.
7.
Greten
FR
,
Grivennikov
SI
.
Inflammation and cancer: triggers, mechanisms, and consequences
.
Immunity
2019
;
51
:
27
41
.
8.
You
T
,
Arsenis
NC
,
Disanzo
BL
,
Lamonte
MJ
.
Effects of exercise training on chronic inflammation in obesity : current evidence and potential mechanisms
.
Sports Med
2013
;
43
:
243
56
.
9.
Pedersen
BK
.
Exercise-induced myokines and their role in chronic diseases
.
Brain Behav Immun
2011
;
25
:
811
6
.
10.
Jakicic
JM
,
Powell
KE
,
Campbell
WW
,
Dipietro
L
,
Pate
RR
,
Pescatello
LS
, et al
.
Physical activity and the prevention of weight gain in adults: a systematic review
.
Med Sci Sports Exerc
2019
;
51
:
1262
9
.
11.
Beavers
KM
,
Brinkley
TE
,
Nicklas
BJ
.
Effect of exercise training on chronic inflammation
.
Clin Chim Acta
2010
;
411
:
785
93
.
12.
Lewis
SJ
,
Gardner
M
,
Higgins
J
,
Holly
JMP
,
Gaunt
TR
,
Perks
CM
, et al
.
Developing the WCRF International/University of Bristol methodology for identifying and carrying out systematic reviews of mechanisms of exposure-cancer associations
.
Cancer Epidemiol Biomarkers Prev
2017
;
26
:
1667
75
.
13.
Drummond
AE
,
Swain
CTV
,
Brown
KA
,
Dixon-Suen
SC
,
Boing
L
,
van Roekel
EH
, et al
.
Linking physical activity to breast cancer via sex steroid hormones, part 2: the effect of sex steroid hormones on breast cancer risk
.
Cancer Epidemiol Biomarkers Prev
2022
;
31
:
28
37
.
14.
Swain
CTV
,
Drummond
AE
,
Boing
L
,
Milne
RL
,
English
DR
,
Brown
KA
, et al
.
Linking physical activity to breast cancer via sex hormones, part 1: the effect of physical activity on sex steroid hormones
.
Cancer Epidemiol Biomarkers Prev
2022
;
31
:
16
27
.
15.
Swain
CTV
,
Drummond
AE
,
Milne
RL
,
English
DR
,
Brown
KA
,
Chong
JE
, et al
.
Linking physical activity to breast cancer risk via insulin/insulin-like growth factor signaling system, part 1: the effect of physical activity on the insulin/insulin-like growth factor signaling system
.
Cancer Epidemiol Biomarkers Prev
2022
;
31
:
2106
15
.
16.
Drummond
AE
,
Swain
CTV
,
Milne
RL
,
English
DR
,
Brown
KA
,
Skinner
TL
, et al
.
Linking physical activity to breast cancer risk via the insulin/insulin-like growth factor signaling system, part 2: the effect of insulin/insulin-like growth factor signaling on breast cancer risk
.
Cancer Epidemiol Biomarkers Prev
2022
;
31
:
2116
25
.
17.
Lou
MW
,
Drummond
AE
,
Swain
CT
,
Milne
RL
,
English
DR
,
Brown
KA
, et al
.
Linking physical activity to breast cancer via inflammation, part 2: the effect of inflammation on breast cancer risk
.
Cancer Epidemiol Biomarkers Prev
2023
;
32
:
597
605
.
18.
Page
MJ
,
McKenzie
JE
,
Bossuyt
PM
,
Boutron
I
,
Hoffmann
TC
,
Mulrow
CD
, et al
.
The Prisma 2020 statement: an updated guideline for reporting systematic reviews
.
BMJ
2021
;
372
:
n71
.
19.
University of Bristol
.
Temmpo: text mining for mechanism prioritisation. Available from
: https://www.temmpo.org.uk/.
20.
Higgins
JP
,
Altman
DG
,
Gotzsche
PC
,
Juni
P
,
Moher
D
,
Oxman
AD
, et al
.
The Cochrane collaboration's tool for assessing risk of bias in randomised trials
.
BMJ
2011
;
343
:
d5928
.
21.
Morgan
RL
,
Thayer
KA
,
Santesso
N
,
Holloway
AC
,
Blain
R
,
Eftim
SE
, et al
.
A risk of bias instrument for non-randomized studies of exposures: A users' guide to its application in the context of grade
.
Environ Int
2019
;
122
:
168
84
.
22.
Sterne
JA
,
Hernán
MA
,
Reeves
BC
,
Savović
J
,
Berkman
ND
,
Viswanathan
M
, et al
.
Robins-i: a tool for assessing risk of bias in non-randomised studies of interventions
.
BMJ
2016
;
355
:
i4919
.
23.
Skrivankova
VW
,
Richmond
RC
,
Woolf
BAR
,
Yarmolinsky
J
,
Davies
NM
,
Swanson
SA
, et al
.
Strengthening the reporting of observational studies in epidemiology using mendelian randomization: the STROBE-MR statement
.
JAMA
2021
;
326
:
1614
21
.
24.
Guyatt
GH
,
Oxman
AD
,
Vist
GE
,
Kunz
R
,
Falck-Ytter
Y
,
Alonso-Coello
P
, et al
.
Grade: an emerging consensus on rating quality of evidence and strength of recommendations
.
BMJ
2008
;
336
:
924
6
.
25.
Abbenhardt
C
,
McTiernan
A
,
Alfano
CM
,
Wener
MH
,
Campbell
KL
,
Duggan
C
, et al
.
Effects of individual and combined dietary weight loss and exercise interventions in postmenopausal women on adiponectin and leptin levels
.
J Intern Med
2013
;
274
:
163
75
.
26.
Alhindawi
M
.
Effects of aerobic training on inflammation marker and CVD in women
.
J Phys Educ Sport
2013
;
13
:
452
7
.
27.
Arikawa
AY
,
Thomas
W
,
Schmitz
KH
,
Kurzer
MS
.
Sixteen weeks of exercise reduces c-reactive protein levels in young women
.
Med Sci Sports Exerc
2011
;
43
:
1002
9
.
28.
Campbell
PT
,
Campbell
KL
,
Wener
MH
,
Wood
BL
,
Potter
JD
,
McTiernan
A
, et al
.
A yearlong exercise intervention decreases CRP among obese postmenopausal women
.
Med Sci Sports Exerc
2009
;
41
:
1533
9
.
29.
Chagas
EFB
,
Bonfim
MR
,
Turi
BC
,
Brondino
NCM
,
Monteiro
HL
.
Effect of moderate-intensity exercise on inflammatory markers among postmenopausal women
.
J Phys Act Health
2017
;
14
:
479
85
.
30.
Chow
BC
,
Li
S
,
Zhu
X
,
Jiao
J
,
Quach
B
,
Baker
JS
, et al
.
Effects of descending or ascending stair exercise on body composition, insulin sensitivity, and inflammatory markers in young Chinese women with obesity: a randomized controlled trial
.
J Sports Sci
2021
;
39
:
496
502
.
31.
Friedenreich
CM
,
Neilson
HK
,
Woolcott
CG
,
Wang
Q
,
Stanczyk
FZ
,
McTiernan
A
, et al
.
Inflammatory marker changes in a yearlong randomized exercise intervention trial among postmenopausal women
.
Cancer Prev Res
2012
;
5
:
98
108
.
32.
Friedenreich
CM
,
O'Reilly
R
,
Shaw
E
,
Stanczyk
FZ
,
Yasui
Y
,
Brenner
DR
, et al
.
Inflammatory marker changes in postmenopausal women after a year-long exercise intervention comparing high versus moderate volumes
.
Cancer Prev Res
2016
;
9
:
196
203
.
33.
Friedenreich
CM
,
Wang
Q
,
Yasui
Y
,
Stanczyk
FZ
,
Duha
A
,
Brenner
DR
, et al
.
Long-term effects of moderate versus high durations of aerobic exercise on biomarkers of breast cancer risk: follow-up to a randomized controlled trial
.
Cancer Epidemiol Biomarkers Prev
2019
;
28
:
1725
34
.
34.
Gomez-Tomas
C
,
Chulvi-Medrano
I
,
Carrasco
JJ
,
Alakhdar
Y
.
Effect of a 1-year elastic band resistance exercise program on cardiovascular risk profile in postmenopausal women
.
Menopause
2018
;
25
:
1004
10
.
35.
Henagan
TM
,
Phillips
MD
,
Cheek
DJ
,
Kirk
KM
,
Barbee
JJ
,
Stewart
LK
.
The melanocortin 3 receptor: a novel mediator of exercise-induced inflammation reduction in postmenopausal women?
J Aging Res
2011
;
2011
:
512593
.
36.
Henriquez
S
,
Monsalves-Alvarez
M
,
Jimenez
T
,
Barrera
G
,
Hirsch
S
,
de la Maza
MP
, et al
.
Effects of two training modalities on body fat and insulin resistance in postmenopausal women
.
J Strength Cond Res
2017
;
31
:
2955
64
.
37.
Imayama
I
,
Ulrich
CM
,
Alfano
CM
,
Wang
C
,
Xiao
L
,
Wener
MH
, et al
.
Effects of a caloric restriction weight loss diet and exercise on inflammatory biomarkers in overweight/obese postmenopausal women: a randomized controlled trial
.
Cancer Res
2012
;
72
:
2314
26
.
38.
Lee
MG
,
Park
KS
,
Kim
DU
,
Choi
SM
,
Kim
HJ
.
Effects of high-intensity exercise training on body composition, abdominal fat loss, and cardiorespiratory fitness in middle-aged Korean females
.
Appl Physiol Nutr Metab
2012
;
37
:
1019
27
.
39.
Mason
C
,
Foster-Schubert
KE
,
Imayama
I
,
Xiao
L
,
Kong
A
,
Campbell
KL
, et al
.
History of weight cycling does not impede future weight loss or metabolic improvements in postmenopausal women
.
Metabolism
2013
;
62
:
127
36
.
40.
Mediano
MF
,
Neves
FA
,
Cunha
AC
,
Souza
EP
,
Moura
AS
,
Sichieri
R
.
Changes in body weight, c-reactive protein, and total adiponectin in non-obese women after 12 months of a small-volume, home-based exercise program
.
Clinics
2013
;
68
:
1121
7
.
41.
Mogharnasi
M
,
TaheriChadorneshin
H
,
Abbasi-Deloei
N
.
Effect of exercise training type on plasma levels of vaspin, nesfatin-1, and high-sensitivity c-reactive protein in overweight and obese women
.
Obesity Medicine
2019
;
13
:
34
8
.
42.
Nono Nankam
PA
,
Mendham
AE
,
De Smidt
MF
,
Keswell
D
,
Olsson
T
,
Bluher
M
, et al
.
Changes in systemic and subcutaneous adipose tissue inflammation and oxidative stress in response to exercise training in obese Black African women
.
J Physiol
2020
;
598
:
503
15
.
43.
Olson
TP
,
Dengel
DR
,
Leon
AS
,
Schmitz
KH
.
Changes in inflammatory biomarkers following one-year of moderate resistance training in overweight women
.
Int J Obes
2007
;
31
:
996
1003
.
44.
Ozcan
O
,
Bostanci
MO
,
Cicek
G
,
Yamaner
F
.
The effects of two different exercise programmes on adipose tissue hormones in sedentary middle-aged women
.
Arch Physiol Biochem
2015
;
121
:
50
5
.
45.
Phillips
MD
,
Patrizi
RM
,
Cheek
DJ
,
Wooten
JS
,
Barbee
JJ
,
Mitchell
JB
.
Resistance training reduces subclinical inflammation in obese, postmenopausal women
.
Med Sci Sports Exerc
2012
;
44
:
2099
110
.
46.
Strandberg
E
,
Edholm
P
,
Ponsot
E
,
Wahlin-Larsson
B
,
Hellmen
E
,
Nilsson
A
, et al
.
Influence of combined resistance training and healthy diet on muscle mass in healthy elderly women: a randomized controlled trial
.
J Appl Physiol
2015
;
119
:
918
25
.
47.
Tartibian
B
,
FitzGerald
LZ
,
Azadpour
N
,
Maleki
BH
.
A randomized controlled study examining the effect of exercise on inflammatory cytokine levels in post-menopausal women
.
Post Reprod Health
2015
;
21
:
9
15
.
48.
Tartibian
B
,
Hajizadeh Maleki
B
,
Kanaley
J
,
Sadeghi
K
.
Long-term aerobic exercise and omega-3 supplementation modulate osteoporosis through inflammatory mechanisms in post-menopausal women: a randomized, repeated measures study
.
Nutr Metab
2011
;
8
:
71
.
49.
Tomeleri
CM
,
Souza
MF
,
Burini
RC
,
Cavaglieri
CR
,
Ribeiro
AS
,
Antunes
M
, et al
.
Resistance training reduces metabolic syndrome and inflammatory markers in older women: a randomized controlled trial
.
J Diabetes
2018
;
10
:
328
37
.
50.
van Gemert
WA
,
May
AM
,
Schuit
AJ
,
Oosterhof
BY
,
Peeters
PH
,
Monninkhof
EM
.
Effect of weight loss with or without exercise on inflammatory markers and adipokines in postmenopausal women: the shape-2 trial, a randomized controlled trial
.
Cancer Epidemiol Biomarkers Prev
2016
;
25
:
799
806
.
51.
Davis
J
,
Murphy
M
,
Trinick
T
,
Duly
E
,
Nevill
A
,
Davison
G
.
Acute effects of walking on inflammatory and cardiovascular risk in sedentary post-menopausal women
.
J Sports Sci
2008
;
26
:
303
9
.
52.
Lustosa
LP
,
Maximo Pereira
LS
,
Coelho
FM
,
Pereira
DS
,
Silva
JP
,
Parentoni
AN
, et al
.
Impact of an exercise program on muscular and functional performance and plasma levels of interleukin 6 and soluble receptor tumor necrosis factor in prefrail community-dwelling older women: a randomized controlled trial
.
Arch Phys Med Rehabil
2013
;
94
:
660
6
.
53.
Miles
MP
,
Horrigan
LC
,
Jay
SE
,
Brown
KM
,
Porter
JW
,
Steward
AN
.
Concentric and eccentric exercise, glycemic responses to a postexercise meal, and inflammation in women with high versus low waist circumference
.
Appl Physiol Nutr Metab
2016
;
41
:
1262
70
.
54.
Barba-Moreno
L
,
Alfaro-Magallanes
VM
,
de Jonge
X
,
Diaz
AE
,
Cupeiro
R
,
Peinado
AB
.
Hepcidin and interleukin-6 responses to endurance exercise over the menstrual cycle
.
Eur J Sport Sci
2022
;
22
:
218
26
.
55.
Giraldo
E
,
Garcia
JJ
,
Hinchado
MD
,
Ortega
E
.
Exercise intensity-dependent changes in the inflammatory response in sedentary women: role of neuroendocrine parameters in the neutrophil phagocytic process and the pro-/anti-inflammatory cytokine balance
.
NeuroImmunoModulation
2009
;
16
:
237
44
.
56.
Gmiat
A
,
Micielska
K
,
Kozlowska
M
,
Flis
DJ
,
Smaruj
M
,
Kujach
S
, et al
.
The impact of a single bout of high intensity circuit training on myokines' concentrations and cognitive functions in women of different age
.
Physiol Behav
2017
;
179
:
290
7
.
57.
Jamurtas
AZ
,
Garyfallopoulou
A
,
Theodorou
AA
,
Zalavras
A
,
Paschalis
V
,
Deli
CK
, et al
.
A single bout of downhill running transiently increases homa-ir without altering adipokine response in healthy adult women
.
Eur J Appl Physiol
2013
;
113
:
2925
32
.
58.
Kurgan
N
,
McKee
K
,
Calleja
M
,
Josse
AR
,
Klentrou
P
.
Cytokines, adipokines, and bone markers at rest and in response to plyometric exercise in obese vs normal weight adolescent females
.
Front Endocrinol
2020
;
11
:
531926
.
59.
Phillips
MD
,
Flynn
MG
,
McFarlin
BK
,
Stewart
LK
,
Timmerman
KL
,
Ji
H
.
Resistive exercise blunts LPS-stimulated TNF-alpha and IL-1 beta
.
Int J Sports Med
2008
;
29
:
102
9
.
60.
Phillips
MD
,
Flynn
MG
,
McFarlin
BK
,
Stewart
LK
,
Timmerman
KL
.
Resistance training at eight-repetition maximum reduces the inflammatory milieu in elderly women
.
Med Sci Sports Exerc
2010
;
42
:
314
25
.
61.
Riesco
E
,
Tessier
S
,
Lacaille
M
,
Perusse
F
,
Cote
M
,
Despres
JP
, et al
.
Impact of a moderate-intensity walking program on cardiometabolic risk markers in overweight to obese women: Is there any influence of menopause?
Menopause
2013
;
20
:
185
93
.
62.
Romero-Parra
N
,
Barba-Moreno
L
,
Rael
B
,
Alfaro-Magallanes
VM
,
Cupeiro
R
,
Diaz
AE
, et al
.
Influence of the menstrual cycle on blood markers of muscle damage and inflammation following eccentric exercise
.
Int J Environ Res Public Health
2020
;
17
:
1618
.
63.
Serviente
C
,
Troy
LM
,
de Jonge
M
,
Shill
DD
,
Jenkins
NT
,
Witkowski
S
.
Endothelial and inflammatory responses to acute exercise in perimenopausal and late postmenopausal women
.
Am J Physiol Regul Integr Comp Physiol
2016
;
311
:
R841
R50
.
64.
Razmjou
S
,
Bastard
JP
,
Doucet
E
,
Rabasa-Lhoret
R
,
Fellahi
S
,
Lavoie
JM
, et al
.
Effect of the menopausal transition and physical activity energy expenditure on inflammatory markers: a Monet group study
.
Menopause
2016
;
23
:
1330
8
.
65.
Khalafi
M
,
Malandish
A
,
Rosenkranz
SK
.
The impact of exercise training on inflammatory markers in postmenopausal women: a systemic review and meta-analysis
.
Exp Gerontol
2021
;
150
:
111398
.
66.
Monteiro-Junior
RS
,
de Tarso Maciel-Pinheiro
P
,
da Matta Mello Portugal
E
,
da Silva Figueiredo
LF
,
Terra
R
,
Carneiro
LSF
, et al
.
Effect of exercise on inflammatory profile of older persons: systematic review and meta-analyses
.
J Phys Act Health
2018
;
15
:
64
71
.
67.
Petersen
AM
,
Pedersen
BK
.
The anti-inflammatory effect of exercise
.
J Appl Physiol
2005
;
98
:
1154
62
.
68.
Bassuk
SS
,
Manson
JE
.
Epidemiological evidence for the role of physical activity in reducing risk of type 2 diabetes and cardiovascular disease
.
J Appl Physiol
2005
;
99
:
1193
204
.
69.
Bay
ML
,
Pedersen
BK
.
Muscle-organ crosstalk: focus on immunometabolism
.
Front Physiol
2020
;
11
:
567881
.
This open access article is distributed under the Creative Commons Attribution 4.0 International (CC BY 4.0) license.

Supplementary data